Adicet Bio posts September 2026 investor presentation
Adicet Bio posted a September 2026 investor presentation highlighting prula-cel clinical progress and IND-cleared ADI-212 with near-term clinic timelines.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.